Get the Stockscreener App
1.64
5.20%
-0.09
After Hours:
1.64
China Pharma Holdings Inc. stock is traded at $1.64, with a volume of 7,623.
It is down -5.20% in the last 24 hours and down -15.90% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$1.73
Open:
$1.67
24h Volume:
7,623
Relative Volume:
0.16
Market Cap:
$5.35M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-4.881
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
-9.69%
1M Performance:
-15.90%
6M Performance:
-23.72%
1Y Performance:
-36.56%
1-Day Range:
$1.64
$1.69
1-Week Range:
$1.64
$1.85
52-Week Range:
$1.20
$3.35
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.64 | 5.64M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
Will China Pharma Holdings Inc. (XQJ0) stock outperform foreign stocks2025 Analyst Calls & Consistent Growth Equity Picks - newser.com
Can China Pharma Holdings Inc. (XQJ0) stock expand revenue streamsBreakout Watch & Safe Swing Trade Setups - newser.com
What machine learning models say about China Pharma Holdings Inc.July 2025 Momentum & Entry and Exit Point Strategies - newser.com
Can China Pharma Holdings Inc. stock surprise markets with earningsEntry Point & AI Powered Buy/Sell Recommendations - newser.com
Key resistance and support levels for China Pharma Holdings Inc.Trade Entry Summary & Low Risk Entry Point Tips - newser.com
Why China Pharma Holdings Inc. is moving todayEarnings Summary Report & Free Safe Capital Growth Stock Tips - newser.com
Will China Pharma Holdings Inc. (XQJ0) stock sustain bullish trend into 2025July 2025 Levels & Reliable Momentum Entry Alerts - newser.com
Using AI based signals to follow China Pharma Holdings Inc.Portfolio Return Report & Fast Gain Swing Trade Alerts - newser.com
Is China Pharma Holdings Inc. (XQJ0) stock safe for risk averse investors2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - newser.com
Does China Pharma Holdings Inc. qualify in momentum factor screening2025 Investor Takeaways & Long-Term Growth Portfolio Plans - newser.com
Why analysts raise outlook for China Pharma Holdings Inc. stockJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Has China Pharma Holdings Inc. formed a bullish divergence2025 Geopolitical Influence & Daily Chart Pattern Signals - newser.com
Does China Pharma Holdings Inc. stock trade below intrinsic valueWeekly Investment Report & Fast Entry Momentum Alerts - newser.com
Will China Pharma Holdings Inc. stock gain from lower inflationBull Run & Daily Risk Controlled Trade Plans - newser.com
Is China Pharma Holdings Inc. trending in predictive chart modelsJuly 2025 Recap & Technical Pattern Based Buy Signals - newser.com
Pattern recognition hints at China Pharma Holdings Inc. upsideTrade Ideas & Scalable Portfolio Growth Methods - newser.com
Is China Pharma Holdings Inc. stock a buy for dividend portfoliosDip Buying & Safe Swing Trade Setups - newser.com
Will China Pharma Holdings Inc. stock outperform value peersWeekly Trading Summary & AI Optimized Trade Strategies - newser.com
Published on: 2025-10-30 06:02:29 - newser.com
What high frequency data says about China Pharma Holdings Inc.Sell Signal & Weekly Return Optimization Plans - newser.com
What catalysts could drive China Pharma Holdings Inc. stock higher - newser.com
How China Pharma Holdings Inc. stock trades during market volatilityQuarterly Market Review & Capital Efficiency Focused Strategies - newser.com
Can China Pharma Holdings Inc. (XQJ0) stock surprise markets with earnings2025 Pullback Review & AI Driven Price Forecasts - newser.com
Is Quint Digital Limiteds Business Model Sustainable Long TermCapital Gains Strategies & Low Cost Portfolio Ideas - earlytimes.in
What technical patterns form on China Pharma Holdings Inc. (XQJ0) stock chartsEarnings Miss & Low Drawdown Momentum Trade Ideas - newser.com
How to monitor China Pharma Holdings Inc. with trend dashboardsGlobal Markets & Risk Managed Investment Signals - newser.com
Why China Pharma Holdings Inc. stock attracts high net worth investorsMarket Sentiment Report & Daily Entry Point Alerts - Fundação Cultural do Pará
Can China Pharma Holdings Inc. stock withstand sector downturnsWeekly Profit Analysis & Weekly High Return Forecasts - newser.com
China Pharma Holdings Inc Stock Analysis and ForecastLow Beta Stocks & Free Dynamic Investment Techniques - earlytimes.in
Is China Pharma Holdings Inc. stock a top pick in earnings seasonMarket Volume Report & Daily Risk Controlled Trade Plans - Fundação Cultural do Pará
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):